ACCESS Act of 2024

Support for reproductive rights in the following legislation and government actions: H.R.12 / S.701, Womens Health Protection Act of 2023 HR. 7056 / S. 3612, Access to Family Building Act HR. 7841, Reproductive Data Privacy and Protection Act H.R. 1838 / S. 1098, Global Health Empowerment and Rights Act H.R. 1723 / S. 929, Abortion is Health Care Everywhere Act of 2023 S. 3983, Abortion Care Capacity Enhancement and Support Services (ACCESS) Act of 2024 HR. 7820, Abortion Care Awareness Act of 2024 H. RES. 1083 / S. Res. 588. Resolution Recognizing Black Midwives Day H.R.4418, Military Access to Reproductive Care and Health (MARCH) for Military Servicemembers Act S.1606 - Black Maternal Health Momnibus Act HR. 4303, Abortion Justice Act of 2023 S. 4063, State Public Option Act H.Con.Res.95 / S.Con.Res 30, Expressing support for the recognition of March 10, 2024 as Abortion Provider Appreciation Day Supporting efforts to protect nationwide access to mifepristone in light of the Alliance for Hippocratic Medicine v. FDA case.   Inclusion of the contraception without co-pay provision for servicemembers and their dependents from S. 1527, the Access to Contraception for Servicemembers and Dependents Act of 2023 in the National Defense Authorization Act for Fiscal Year 2025 Provided technical assistance on administrative options re: abortion access in ban states. Consulted on congressional actions focused on post-Dobbs vs. Jackson Women's Health Organization abortion access. Opposing all the provisions in: H.R. 6918 / S. 3741, Supporting Pregnant and Parenting Women and Families Act HR. 6914, Pregnant Students Rights Act

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Abortion access (general); Access to mifepristone (general); Contraception (general); Maternal mortality and morbidity (general); H.R. 1117, Advancing Safe Medications for Moms and Babies Act; Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of ob-gyn units in rural hospitals on patient access to care and maternal morbidity and mortality; H.R. 3305/S. 1606, Black Maternal Health Momnibus Act; H.R. 1202/S. 704, Resident Education Deferred Interest (REDI) Act; H.R. 2389/S. 1302, Resident Physician Shortage Reduction Act of 2023; H.R. 2569, Doctors of Community (DOC) Act; Teaching Health Center Graduate Medication Education (general); H.R. 3838/S. 2415, Preventing Maternal Deaths Reauthorization Act of 2023; H.R. 3226/S. 1573, PREEMIE Reauthorization Act of 2023; Inclusion of pregnant and lactating individuals in research (general); Telemedicine (general); H.R. 5012/S. 2647, SHINE for Autumn Act; H.R. 4581/S. 2231, Maternal and Child Health Stillbirth Prevention Act; H.R. 7056/S. 3612, Access to Family Building Act; H.R. 6918/S. 3741, Supporting Pregnant and Parenting Women and Families Act; H.R. 6914/S. 2974, Pregnant Students Rights Act; H.R. 7153/S. 3679, Dr. Lorna Breen Health Care Provider Protection Act; Family Health Affordability Act; S. 712, Connected MOM Act; H.R. 7050, Substance Use Disorder Workforce Act; H.R. 7059/S. 3983, ACCESS Act; Health Insurance Portability and Accountability Act (general); Patient-physician relationship (general); Menopause research, training, and education (general); Alliance for Innovation on Maternal Health; Residency programs in obstetrics and gynecology (general); Abortion training in obstetrics and gynecology residency programs (general); Obstetrician-gynecologist workforce (general); H.R. 5568/S. 2846, CARE for Moms Act; H.R. 6743, WARM Act; Reproductive health data privacy (general); Substance use disorder during pregnancy (general); Physician burnout (general); Maternal mental health (general); Artificial intelligence in health care (general); Coverage for infertility (general); Protections for in vitro fertilization (general); Restrictions on menthol cigarettes and flavored cigars (general); Obstetric unit closures (general); White House Initiative on Womens Health Research (general); COVID-19 vaccine (general); Vaccine safety systems (general); Pediatric Subspecialty Loan Repayment Program; Over-the-counter contraception (general)

Client expense: $170,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office

Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to third party servicing of medical devices Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of COVID-19 diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to COVID-19 Clinical Testing & Testing Supplies Issues related to Public Health Emergency Preparedness Issues related to COVID-19 Clinical Testing and Testing Supplies Issues related to consumer and health data privacy Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation, H.R. 2457 PFAS Action Act Issues related to H.R. 6833 Continuing Appropriations and Ukraine Supplemental Appropriations Act Issues related to cyber security including H.R. 7084/S. 3983, PATCH Act and S. 4336 Strengthening Cybersecurity for Medical Devices Act

Client expense: $840,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office